Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C23H31NO2 |
| Molecular Weight | 353.4977 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC[C@@H](OC(C)=O)C(C[C@@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2
InChI
InChIKey=XBMIVRRWGCYBTQ-XMSQKQJNSA-N
InChI=1S/C23H31NO2/c1-6-22(26-19(3)25)23(17-18(2)24(4)5,20-13-9-7-10-14-20)21-15-11-8-12-16-21/h7-16,18,22H,6,17H2,1-5H3/t18-,22-/m1/s1
| Molecular Formula | C23H31NO2 |
| Molecular Weight | 353.4977 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
DescriptionCurator's Comment: description was created based on several sources, including
https://en.wikipedia.org/wiki/Alphacetylmethadol
Curator's Comment: description was created based on several sources, including
https://en.wikipedia.org/wiki/Alphacetylmethadol
Alphacetylmethadol (INN), aka α-acetylmethadol (AAM), is a synthetic opioid analgesic. Its levorotary enantiomer, levacetylmethadol, is an FDA-approved treatment for opioid addiction. Alphacetylmethadol is very similar in structure to methadone, a widely-prescribed treatment for opioid addiction. In the United States, it is a Schedule I controlled substance under the Controlled Substances Act with an ACSCN of 9603 and a 2013 annual manufacturing quota of 2 grams. Studies in rats indicate that alphacetylmethadol also evokes the heroin-like discriminative stimulus effects.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:28:59 GMT 2023
by
admin
on
Fri Dec 15 15:28:59 GMT 2023
|
| Record UNII |
BXF83S0HEL
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
DEA NO. |
9603
Created by
admin on Fri Dec 15 15:28:59 GMT 2023 , Edited by admin on Fri Dec 15 15:28:59 GMT 2023
|
||
|
NCI_THESAURUS |
C241
Created by
admin on Fri Dec 15 15:28:59 GMT 2023 , Edited by admin on Fri Dec 15 15:28:59 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DB01555
Created by
admin on Fri Dec 15 15:28:59 GMT 2023 , Edited by admin on Fri Dec 15 15:28:59 GMT 2023
|
PRIMARY | |||
|
BXF83S0HEL
Created by
admin on Fri Dec 15 15:28:59 GMT 2023 , Edited by admin on Fri Dec 15 15:28:59 GMT 2023
|
PRIMARY | |||
|
C72134
Created by
admin on Fri Dec 15 15:28:59 GMT 2023 , Edited by admin on Fri Dec 15 15:28:59 GMT 2023
|
PRIMARY | |||
|
SUB05363MIG
Created by
admin on Fri Dec 15 15:28:59 GMT 2023 , Edited by admin on Fri Dec 15 15:28:59 GMT 2023
|
PRIMARY | |||
|
100000087449
Created by
admin on Fri Dec 15 15:28:59 GMT 2023 , Edited by admin on Fri Dec 15 15:28:59 GMT 2023
|
PRIMARY | |||
|
DTXSID70169198
Created by
admin on Fri Dec 15 15:28:59 GMT 2023 , Edited by admin on Fri Dec 15 15:28:59 GMT 2023
|
PRIMARY | |||
|
351
Created by
admin on Fri Dec 15 15:28:59 GMT 2023 , Edited by admin on Fri Dec 15 15:28:59 GMT 2023
|
PRIMARY | |||
|
17199-58-5
Created by
admin on Fri Dec 15 15:28:59 GMT 2023 , Edited by admin on Fri Dec 15 15:28:59 GMT 2023
|
PRIMARY | |||
|
22308
Created by
admin on Fri Dec 15 15:28:59 GMT 2023 , Edited by admin on Fri Dec 15 15:28:59 GMT 2023
|
PRIMARY | |||
|
CHEMBL2107793
Created by
admin on Fri Dec 15 15:28:59 GMT 2023 , Edited by admin on Fri Dec 15 15:28:59 GMT 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
APPROXIMATE PURE ANHYDROUS DRUG CONTENT (IN PERCENT)
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
